New blood test for genetic changes in advanced prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a new way to find genetic changes in metastatic prostate cancer using a blood test (liquid biopsy) when tumor tissue is not available. It may help doctors choose better treatments for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have metastatic prostate cancer (cancer that has spread from the prostate to other parts of the body).
- A sample of your tumor tissue is not available or not good enough for standard genetic testing.
- You are willing to sign a written consent form agreeing to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks for specific DNA repair changes in men with prostate cancer. It tests if these genetic features can help guide treatment decisions. You may join if you have high-risk localized, newly metastatic, or advanced prostate cancer and have tissue available for testing.
This study checks whether certain blood markers can help predict how well people with prostate cancer will respond to therapy. It may help doctors choose the most effective treatment sooner by using information from your blood.
This trial uses a simple blood test to look for two specific gene changes (ESR-1 and gBRCA) in people with hormone receptor-positive, HER2-negative breast cancer that has spread. It aims to detect these mutations earlier and help guide future treatment decisions.
This study looks at using a simple blood test (liquid biopsy) to read tumor DNA and understand how it could affect treatment decisions. It is for adults with metastatic prostate cancer who are about to start, are receiving, or recently finished treatment.
This study analyzes tumor tissue and blood samples from men with advanced prostate cancer to understand genetic changes that may affect treatment choices. Results may help doctors personalize your treatment plan.
This trial studies a blood test that looks for tumor DNA in men with high-risk or advanced prostate cancer. It may help doctors understand the cancer better and guide treatment decisions.
Hear when a new Metastatic Prostate Cancer (mPC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.